402 skills · sorted by relevance
Screen study titles, abstracts, and full texts against confirmed eligibility rules. Two AI reviewers assess records separately, with a third resolving conflicts, while outputs document exclusion reasons, selection counts, and the methods used.
Screening Assistant - AI-PRISMA 6-dimension screening with Groq LLM (100x cheaper) Supports two project types with different confidence thresholds Use when: screening papers, PRISMA screening, inclusion/exclusion criteria Triggers: screen papers, PRISMA screening, inclusion criteria, exclusion criteria, AI screening
The English summary is being prepared. Showing the original description.
Adjudicates whether a hit generated by sanctions, PEP, or adverse-media screening is a true positive, false positive, or requires human escalation. Use whenever a user presents a screening alert, a name match against a watchlist (OFAC SDN, EU consolidated list, UK OFSI, UN list, PEP list, adverse media hit, etc.), or asks to clear a screening hit / reduce false positives / determine whether a flagged name is actually the listed party. Use even when the user describes the task casually — "is this person actually on the sanctions list", "did we get a real match", "clear this alert", "I have a hit on X" — these are all screening-adjudication tasks. Produces a deterministic determination with full audit trail (structured JSON + human-readable narrative). Designed for use by compliance analysts and screening systems.
The English summary is being prepared. Showing the original description.
Generate a spreadsheet of test entries — newly designated names from OFAC, OFSI, and EU sanctions lists plus deliberate variations of those names — to validate that a sanctions screening system catches fresh designations and is tuned to the right fuzziness threshold. Use this whenever the user asks for sanctions list update test data, screening regression test data, screening QA, fuzzy match calibration, or wants to verify their screening lists are current. Trigger even if the user doesn't say 'screening' explicitly — phrases like 'test my sanctions list', 'check our SDN coverage', 'is my list up to date', or 'build me a regression set from the latest designations' should also invoke this skill.
The English summary is being prepared. Showing the original description.
Conducts pre-DPIA threshold screening to determine whether a full Data Protection Impact Assessment is required under GDPR Article 35. Applies the EDPB WP248rev.01 nine-criteria test, national supervisory authority blacklists, and organisational risk appetite to produce a documented screening decision. Keywords: threshold screening, DPIA trigger, pre-DPIA, WP248, Article 35(1), blacklist, screening decision.
The English summary is being prepared. Showing the original description.
Screen and evaluate A-share investment opportunities. Adapts the original deal-screening skill for Chinese market data sources, A-share screening criteria, and domestic deal origination. Triggers on "A股标的筛选", "标的筛选", "screening China", "deal screening A-share", "筛选投资标的", or "screen for [criteria]".
The English summary is being prepared. Showing the original description.
Use this skill when a new product feature, vendor, AI use, monitoring tool or change in processing raises the question "do we need a DPIA", or someone asks "DPIA screening", "is this high risk processing", "data protection impact assessment threshold", "privacy impact screening for this feature", "does our AI feature need a DPIA" or "document why we did not do a DPIA". Describes the processing with numbers, tests it against the GDPR cases, the supervisory authority's list and the EDPB-endorsed criteria, reaches a reasoned outcome (required, recommended, not required) with a re-screen trigger, and keeps a screening log for accountability.
The English summary is being prepared. Showing the original description.
Performs structure-based virtual screening using AutoDock Vina, SMINA, GNINA (CNN scoring), and DiffDock-L hybrid workflows with explicit choice rules across rigid vs flexible docking, cross-docking vs self-docking, binding-site detection (P2Rank, fpocket), receptor preparation (PDB2PQR, PROPKA), ligand preparation (meeko, OpenBabel), and ultralarge-library screening (ZINC22, Enamine REAL). Use when screening chemical libraries against a protein target to find candidate binders, ranking docking poses, or selecting a docking workflow for a specific scenario.
The English summary is being prepared. Showing the original description.
Order and interpret lipoprotein(a) [Lp(a)] measurement at least once in a lifetime, apply the risk-enhancer threshold (≥125 nmol/L or ≥50 mg/dL), and run cascade screening of first-degree relatives for premature ASCVD, familial hypercholesterolaemia, or elevated Lp(a) per the 2026 ACC/AHA multisociety dyslipidaemia guideline. Covers the Class 1 lifetime measurement, how elevated Lp(a) affects LLT initiation and intensification, the cascade screening indications, the interaction of Lp(a) with ASCVD risk estimation, and current therapeutic limitations. Use when a clinician asks when to check Lp(a), how often to repeat Lp(a), elevated Lp(a) what next, treatment for high Lp(a), should I screen my patient's family, Lp(a) and statins, cascade screening indications. Grounded in the 2026 ACC/AHA multisociety dyslipidaemia guideline.
The English summary is being prepared. Showing the original description.
Performs structure-based virtual screening using AutoDock Vina, SMINA, GNINA (CNN scoring), and DiffDock-L hybrid workflows with explicit choice rules across rigid vs flexible docking, cross-docking vs self-docking, binding-site detection (P2Rank, fpocket), receptor preparation (PDB2PQR, PROPKA), ligand preparation (meeko, OpenBabel), and ultralarge-library screening (ZINC22, Enamine REAL). Use when screening chemical libraries against a protein target to find candidate binders, ranking docking poses, or selecting a docking workflow for a specific scenario.
The English summary is being prepared. Showing the original description.
Performs structure-based virtual screening using AutoDock Vina, SMINA, GNINA (CNN scoring), and DiffDock-L hybrid workflows with explicit choice rules across rigid vs flexible docking, cross-docking vs self-docking, binding-site detection (P2Rank, fpocket), receptor preparation (PDB2PQR, PROPKA), ligand preparation (meeko, OpenBabel), and ultralarge-library screening (ZINC22, Enamine REAL). Use when screening chemical libraries against a protein target to find candidate binders, ranking docking poses, or selecting a docking workflow for a specific scenario.
The English summary is being prepared. Showing the original description.
Performs structure-based virtual screening using AutoDock Vina, SMINA, GNINA (CNN scoring), and DiffDock-L hybrid workflows with explicit choice rules across rigid vs flexible docking, cross-docking vs self-docking, binding-site detection (P2Rank, fpocket), receptor preparation (PDB2PQR, PROPKA), ligand preparation (meeko, OpenBabel), and ultralarge-library screening (ZINC22, Enamine REAL). Use when screening chemical libraries against a protein target to find candidate binders, ranking docking poses, or selecting a docking workflow for a specific scenario.
The English summary is being prepared. Showing the original description.
Screen incoming investment opportunities against a fund’s criteria using company sale memoranda, short deal summaries, or broker materials. Extract financials and risks, assess fit, and produce a one-page memo with a recommendation and first-call questions.
Extract identity, ownership, control, and source-of-funds details from investor or client onboarding documents into a structured JSON record. Inventory the submitted documents and flag obvious missing or expired items before passing the information to KYC screening rules.
Prepare raw credit data for pre-loan modeling by checking data quality and screening variables. Review missing values, predictive usefulness, stability, noise, and correlation, then export an Excel report with organization-level statistics and cleaning results.
Use when screening differentially expressed genes from a bulk expression matrix between two user-specified groups, producing DEG tables, a volcano plot, and a clustered heatmap. Triggers include DEG analysis, volcano plot, clustered heatmap, limma-based two-group comparison, and case-vs-control screening. NOT for single-cell RNA-seq, multi-group contrasts, count-model workflows such as DESeq2/edgeR, or non-expression omics data.
The English summary is being prepared. Showing the original description.
Rapid NDA screening with GREEN/YELLOW/RED classification. 10-point checklist for incoming NDAs. Use when triaging NDAs, screening non-disclosure agreements, or routing NDAs for approval.
The English summary is being prepared. Showing the original description.
Guides the Privacy Threshold Analysis screening process to determine whether a full DPIA is required. Provides a quick-screen questionnaire, threshold criteria based on WP248rev.01, escalation triggers, and documentation requirements. Activate when evaluating new processing activities, system changes, or procurement decisions. Keywords: PTA, privacy threshold analysis, DPIA screening, quick-screen, threshold criteria, WP248, escalation triggers.
The English summary is being prepared. Showing the original description.
Manages privacy compliance for employee background checks including criminal record processing under Art. 10 GDPR, DBS checks (UK), national law variations, and reference verification. Applies proportionality and data minimisation to pre-employment screening, defines retention limits, and addresses role-based necessity assessments. Keywords: background check, criminal record, Art. 10, DBS, pre-employment screening, vetting, data minimisation, proportionality.
The English summary is being prepared. Showing the original description.
Find Amazon same-niche competitors by ASIN, with multi-dimensional filtering by click conversion rate, composite conversion rate, click volume, sales volume, reviews, ratings, price, and gross margin to identify potential competitors. Triggered when users mention same-niche competitors, ASIN competitor mining, niche competitor analysis, similar product benchmarking, ASIN benchmarking, niche market competitor list, high-conversion competitor screening, Nexscope product mining, niche competitor by ASIN, ASIN competitor analysis, same niche products, similar products discovery, conversion rate comparison, potential competitor screening, Nexscope ASIN mining. Even if users do not explicitly mention "niche" or "same niche", this skill should be triggered whenever the task involves discovering competitor lists or screening potential competitors based on a specific ASIN within the same market segment.
The English summary is being prepared. Showing the original description.
Recommends antihypertensive therapy including mineralocorticoid receptor antagonists (MRAs) for patients with a positive primary aldosteronism (PA) screening test who decline confirmatory testing. Triggers include when a patient has positive screening but refuses additional tests and asks "What should I treat with?" or initiates empiric therapy, with preference for MRAs in typical PA presentations (e.g., spontaneous hypokalemia, resistant hypertension, adrenal tumor on CT).
The English summary is being prepared. Showing the original description.
Provides guidance on acceptable blood sampling conditions for primary aldosteronism screening when ideal early‑morning supine fasting conditions cannot be met. Triggers include when a clinician says “The patient wasn’t fasting/supine” or questions whether non‑ideal sampling affects screening validity.
The English summary is being prepared. Showing the original description.
Recommends switching specific anti-hypertensive medications to reduce false-positive and false-negative screening results for primary aldosteronism. Triggered when a clinician notes 'The patient is on ACE inhibitors/ARBs' or suspects medication interference with screening results.
The English summary is being prepared. Showing the original description.
Determines if PAC/PRA ratio and PAC levels indicate positive or provisionally positive screening for primary aldosteronism. Triggered when a clinician has PAC and PRA results and asks “Is this screening test positive for PA?” or needs to interpret borderline results.
The English summary is being prepared. Showing the original description.